786 related articles for article (PubMed ID: 15971203)
1. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
Paula S; Monson N; Ball WJ
Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
[TBL] [Abstract][Full Text] [Related]
2. A V kappa-J kappa junctional change in an antidigoxin recombinant antibody destroys digoxin-binding activity.
Hudson NW; Bruccoleri RE; Steinrauf LK; Hamilton JA; Mudgett-Hunter M; Margolies MN
J Immunol; 1990 Oct; 145(8):2718-24. PubMed ID: 2120338
[TBL] [Abstract][Full Text] [Related]
3. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional quantitative structure-activity relationship analysis of ligand binding to human sequence antidigoxin monoclonal antibodies using comparative molecular field analysis.
Farr CD; Tabet MR; Ball WJ; Fishwild DM; Wang X; Nair AC; Welsh WJ
J Med Chem; 2002 Jul; 45(15):3257-70. PubMed ID: 12109909
[TBL] [Abstract][Full Text] [Related]
5. Identification of residues in monoclonal antibody NC10.8 that bind to the sweetener N-(p-cyanophenyl)-N'-(diphenylmethyl)guanidinoacetic acid by using radioligand binding, absorption and fluorescence spectroscopy, computer-aided molecular modeling, and site-directed mutagenesis.
Anchin JM; Droupadi PR; DuBois GE; Kellogg MS; Nagarajan S; Carter JS; Linthicum DS
J Immunol; 1994 Oct; 153(7):3059-69. PubMed ID: 8089487
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of antibody specificity. Detailed comparison of five Fab'-steroid complexes.
Arevalo JH; Hassig CA; Stura EA; Sims MJ; Taussig MJ; Wilson IA
J Mol Biol; 1994 Sep; 241(5):663-90. PubMed ID: 8071992
[TBL] [Abstract][Full Text] [Related]
7. The three-dimensional structure of a complex of a murine Fab (NC10. 14) with a potent sweetener (NC174): an illustration of structural diversity in antigen recognition by immunoglobulins.
Guddat LW; Shan L; Broomell C; Ramsland PA; Fan Z; Anchin JM; Linthicum DS; Edmundson AB
J Mol Biol; 2000 Sep; 302(4):853-72. PubMed ID: 10993728
[TBL] [Abstract][Full Text] [Related]
8. Contribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibody.
Schildbach JF; Shaw SY; Bruccoleri RE; Haber E; Herzenberg LA; Jager GC; Jeffrey PD; Panka DJ; Parks DR; Near RI
Protein Sci; 1994 May; 3(5):737-49. PubMed ID: 8061604
[TBL] [Abstract][Full Text] [Related]
9. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the stereoselectivity of an anti-amino acid antibody using molecular modeling and ligand docking.
Ranieri DI; Corgliano DM; Franco EJ; Hofstetter H; Hofstetter O
Chirality; 2008 Mar; 20(3-4):559-70. PubMed ID: 18172831
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody.
Paula S; Tabet MR; Farr CD; Norman AB; Ball WJ
J Med Chem; 2004 Jan; 47(1):133-42. PubMed ID: 14695827
[TBL] [Abstract][Full Text] [Related]
12. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
Paula S; Tabet MR; Ball WJ
Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774
[TBL] [Abstract][Full Text] [Related]
13. Identification of a model cardiac glycoside receptor: comparisons with Na+,K+-ATPase.
Kasturi R; Yuan J; McLean LR; Margolies MN; Ball WJ
Biochemistry; 1998 May; 37(19):6658-66. PubMed ID: 9578549
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin chain recombination among antidigoxin antibodies by hybridoma-hybridoma fusion.
Hudson NW; Mudgett-Hunter M; Panka DJ; Margolies MN
J Immunol; 1987 Oct; 139(8):2715-23. PubMed ID: 3655369
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
Axe FU; Bembenek SD; Szalma S
J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for amide hydrolysis catalyzed by the 43C9 antibody.
Thayer MM; Olender EH; Arvai AS; Koike CK; Canestrelli IL; Stewart JD; Benkovic SJ; Getzoff ED; Roberts VA
J Mol Biol; 1999 Aug; 291(2):329-45. PubMed ID: 10438624
[TBL] [Abstract][Full Text] [Related]
17. Highly specific anti-estradiol antibodies: structural characterisation and binding diversity.
Monnet C; Bettsworth F; Stura EA; Le Du MH; Ménez R; Derrien L; Zinn-Justin S; Gilquin B; Sibaï G; Battail-Poirot N; Jolivet M; Ménez A; Arnaud M; Ducancel F; Charbonnier JB
J Mol Biol; 2002 Jan; 315(4):699-712. PubMed ID: 11812141
[TBL] [Abstract][Full Text] [Related]
18. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
Covaceuszach S; Cattaneo A; Lamba D
Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
[TBL] [Abstract][Full Text] [Related]
19. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
